Analyst Ratings for Vitae Pharmaceuticals (VTAE)

VTAE Rating Summary

  |   Expand Research on VTAE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 1.7 / 10   Percentile Rank: 11%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/20/2016 Piper Sandler N/A Downgrade Neutral
(Overweight)
N/A
(N/A)
20.85
(21.00)
0.72% Details
9/15/2016 Wells Fargo N/A Downgrade Equal Weight
(Overweight)
N/A
(N/A)
20.85
(21.00)
0.72% Details